Search clinical trials for: sFlt1

Total 9 results

Centre Hospitalier Metropole Savoie

Completed

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy. (PRECOPE)

Eclampsia | Pre-Eclampsia | HELLP Syndrome | Fetal Death | Placental Abruption | Fetal Growth Retardation, Antenatal

France
CHU de Reims

Completed

sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? (COVIDsFlt1)

CORONAVIRUS INFECTIONS

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAG (ANGIOPAG)

Intrauterine Growth Restriction | Fetal Growth Restriction (FGR)

France
Hadassah Medical Organization
Beth Israel Deaconess Medical Center

Unknown

Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence

Pre-Eclampsia

Israel
Fundació Institut de Recerca de l'Hospital de la...
Fundacion Clinic per a la Recerca Biomédica

Recruiting

sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. (PE37)

Preeclampsia | Intrauterine Growth Restriction | Perinatal Death | Maternal Hypertension | Neonatal Outcome

Spain, Belgium, Czechia, Poland, India
University of Milano Bicocca
San Gerardo Hospital

Recruiting

S Protein and COVID-19: a Monocentric Prospective Study (PROS-Covid)

COVID-19

Italy
Centre Hospitalier Intercommunal Creteil

Active, not recruiting

Interest of sFlt1/PlGF Ratio at Obstetric Emergencies (AngioCHIC)

Pregnancy Complications | Pre-Eclampsia | Suspected Placental Dysfunction, Ruled Out

France
Fundació Institut de Recerca de l'Hospital de la...
Carlos III Health Institute; Spanish Clinical Research Network - SCReN

Completed

Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease (EuroPE)

Preeclampsia

Spain
Centre Hospitalier Universitaire de Nīmes

Completed

The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations (NOH-ANGIO)

Antiphospholipid Syndrome

France

Search clinical trials for: sFlt1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations